Medicinova (MNOV) Enterprise Value (2021 - 2025)
Medicinova (MNOV) has disclosed Enterprise Value for 7 consecutive years, with -$30.8 million as the latest value for Q4 2025.
- On a quarterly basis, Enterprise Value changed N/A to -$30.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$30.8 million, a N/A change, with the full-year FY2025 number at -$30.8 million, changed N/A from a year prior.
- Enterprise Value was -$30.8 million for Q4 2025 at Medicinova, up from -$32.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$30.8 million in Q4 2025 to a low of -$77.8 million in Q2 2021.
- A 5-year average of -$53.6 million and a median of -$52.0 million in 2022 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: surged 30.01% in 2022, then rose 1.9% in 2023.
- Medicinova's Enterprise Value stood at -$71.4 million in 2021, then grew by 26.49% to -$52.5 million in 2022, then rose by 2.87% to -$51.0 million in 2023, then grew by 17.1% to -$42.3 million in 2024, then increased by 27.14% to -$30.8 million in 2025.
- Per Business Quant, the three most recent readings for MNOV's Enterprise Value are -$30.8 million (Q4 2025), -$32.6 million (Q3 2025), and -$34.3 million (Q2 2025).